TruBridge (TBRG) Stephens 26th Annual Investment Conference | NASH2024 summary
Event summary combining transcript, slides, and related documents.
Stephens 26th Annual Investment Conference | NASH2024 summary
8 Jul, 2026Market and demand trends
Labor shortages, especially in rural healthcare and RCM, continue to drive demand for outsourced solutions.
Regulatory changes like HTI-1 and HTI-2 are expected to create opportunities as smaller vendors struggle to comply.
Shifts in Medicare Advantage and Medicaid funding are pushing hospitals to seek efficiency and smarter operations.
Demand is rising for both EHR and RCM, with 60%-70% of EHR deals now including RCM components.
Expansion into larger hospitals (100-400 beds) is gaining traction through consultative, relationship-driven approaches.
Bookings, revenue quality, and growth outlook
Four consecutive quarters of $20M+ bookings achieved through diversified pipeline and improved sales leadership.
Recurring revenue now at 96%, with 40%+ tied to collections, aligning client and company success.
CBO revenue is growing at double digits, driven by faster conversion of bookings and focus on customer retention.
Organic revenue growth is expected to move from flat to mid-to-high single digits, aided by stabilizing EHR and continued RCM momentum.
Attrition management and new product offerings are key to sustaining growth and improving margins.
Operational transformation and margin improvement
Offshoring to Viewgol is progressing, with 30% of business converted and another 30% targeted by end of 2025.
High single-digit million-dollar savings expected from offshoring between early 2024 and end of 2025.
Focus remains on balancing labor cost savings with customer satisfaction to minimize attrition.
EBITDA margin targeted to rise from 16.5% to at least 20% by late 2025, driven by gross margin leverage, operating efficiency, and cost control.
Capital allocation rigor increased, with CapEx as a percent of revenue targeted to fall to 4.5%.
Latest events from TruBridge
- RCM growth and margin gains offset EHR declines as net loss widens and 2024 guidance is reaffirmed.TBRG
Q2 20248 Jul 2026 - Merger and executive compensation proposals both passed by majority stockholder vote.TBRG
EGM 20267 Jul 2026 - Shareholders to vote on a premium cash merger with IKS; board and major holders support the deal.TBRG
Proxy filing4 Jun 2026 - Shareholders to vote on cash merger at $26.25/share; board and major holders support the deal.TBRG
Proxy filing21 May 2026 - Q1 2026 saw $86.3M revenue, rising non-GAAP net income, and a pending IKS acquisition.TBRG
Q1 20268 May 2026 - TruBridge's acquisition by IKS Health targets improved healthcare access and operational stability.TBRG
Proxy filing23 Apr 2026 - IKS Health to acquire TruBridge for $557M, creating a leading healthcare solutions platform.TBRG
Proxy filing23 Apr 2026 - TruBridge will be acquired by IKS for $26.25 per share in cash, pending approvals.TBRG
Proxy filing23 Apr 2026 - Margin gains, strong recurring revenue, and GAAP profitability marked the year.TBRG
Q4 202531 Mar 2026